UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (date of earliest event reported): May 5, 2017
Commission File No. 001-12575
UTAH MEDICAL PRODUCTS, INC.
(Exact name of Registrant as specified in its charter)
|
UTAH
|
87‑0342734
|
|
(State or other jurisdiction of
incorporation or organization)
|
(I.R.S. Employer
Identification No.)
|
7043 South 300 West
Midvale, Utah 84047
Address of principal executive offices
Registrant's telephone number: (801) 566‑1200
ITEM 5.07. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
On May 5, 2017 at the annual meeting, stockholders of the Company approved or indicated their preference on the following matters submitted to them for consideration:
Elected Ernst G. Hoyer as a director of the Company:
For 1,819,712 Withheld 1,054,010 Broker Non Votes 518,656
Elected James H. Beeson as a director of the Company:
For 1,755,857 Withheld 1,117,865 Broker Non Votes 518,656
Ratified the selection of Jones Simkins LLC as the Company's independent public accounting firm for the year ended December 31, 2017:
For 3,314,810 Against 65,155 Abstentions 12,413
Approved, on an advisory basis, the compensation paid to UTMD's named executive officers, including the Compensation Discussion and Analysis, compensation tables and narrative discussion:
For 2,838,920 Against 28,511 Abstentions 6,291 Broker Non Votes 518,656
Indicated, on an advisory basis, their preference for annual stockholder votes on executive compensation:
1 Year 2,325,010 2 Years 10,579 3 Years 534,032 Abstentions 4,101
The Company will include annual advisory stockholder votes on executive compensation in its proxy materials. Annual advisory stockholder votes will be held until at least the next required advisory vote on frequency of stockholder votes on the compensation of executives.
SIGNATURES
Pursuant to the requirements of the Securities Exchanges Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
|
UTAH MEDICAL PRODUCTS, INC.
|
|
|
REGISTRANT
|
|
|
|
|
|
|
|
Date: 5/08/2017
|
By: /s/ Kevin L. Cornwell
|
|
|
Kevin L. Cornwell
|
|
|
CEO
|